Immunotherapeutic Potential of Targeting the Wnt Pathway in Gynecologic Malignancies

Time: 3:30 pm
day: Day One


• How Wnt and β-Catenin can address gynecologic malignancies and chemotherapy resistance
• Identifying biomarkers that can be used in the future to guide treatment decisions
• Exploring mechanisms behind immunosuppressive tumor microenvironments and implications for treatment